Anesthesia for Patients Receiving Psychiatric Medications

Question 1

Class names & mechanism of action

Answer 1

Question 2

Sites of action of antidepressants at noradrenergic (top) and serotonergic (bottom) nerve terminals.

Answer 2

Question 3

Generally continue antidepressants

Answer 3

Question 4

triCyclic antidepressants (TCAs)

Answer 4

Question 5

Anesthesia in patient receiving TCA

Answer 5

Question 6

Anesthesia in patient receiving TCA

What to avoid?

Answer 6

Question 7

Anesthesia in patient receiving TCA on chronic therapy

Answer 7

Question 8

SSRIs - Selective serotonin reuptake inhibitors

Answer 8

Question 9

Anesthesia in patients receiving SSRIs

Answer 9

Question 10

Serotonin Syndrome

Answer 10

Question 11

Monoamine Oxidase Inhibitors (MAOIs)

Answer 11

Question 12

Anesthesia in patients receiving MAOIs

Answer 12

Question 13

Serotonin transport affinity and risk for clinically significant interaction when combined with MAOI

Answer 13

Question 14

Management of serotonin syndrome

Answer 14

Question 15

Other MOAI effects

Answer 15

Question 16

Safe drugs with MOAI

Answer 16

Question 17

Meso-limbic vs. Meso-cortical

Answer 17

Question 18

Dopamine (DA) pathways

Answer 18

Question 19

Antipsychotic agents

Answer 19

Question 20

Antipsychotic therapy

Answer 20

Question 21

Antipsychotic agents – first generation

Answer 21

Question 22

Antipsychotic agents – second generation

Answer 22

Question 23

Anesthesia in patients taking antipsychotic agents

Answer 23

Question 24

Parkinson disease

Answer 24

Question 25

Pharmacotherapy of PD

Answer 25

Question 26

Carbidopa/Levodopa

Answer 26

Question 27

Dopamine agonists

Answer 27

Question 28

enzyme inhibition – especially MOA B

Answer 28

Question 29

Parkinson disease and anesthesia

Answer 29

Question 30

Alzheimer disease pharmacotherapy

Answer 30